Ameritas Investment Partners’s Icosavax, Inc. Common Stock ICVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-2,705
Closed -$42.6K 3101
2023
Q4
$42.6K Buy
2,705
+830
+44% +$7.99K ﹤0.01% 2261
2023
Q3
$14.5K Hold
1,875
﹤0.01% 2676
2023
Q2
$18.6K Hold
1,875
﹤0.01% 2605
2023
Q1
$10.9K Hold
1,875
﹤0.01% 2705
2022
Q4
$18.8K Hold
1,875
﹤0.01% 2594
2022
Q3
$5K Hold
1,875
﹤0.01% 2928
2022
Q2
$10K Hold
1,875
﹤0.01% 2848
2022
Q1
$13K Buy
1,875
+850
+83% +$13.4K ﹤0.01% 2720
2021
Q4
$23K Hold
1,025
﹤0.01% 2588
2021
Q3
$30K Buy
+1,025
New +$34.7K ﹤0.01% 2484

Ameritas Investment Partners's ICVX Position: Q1 2024 in Review

Ameritas Investment Partners sold out of Icosavax, Inc. Common Stock (ICVX) in Q1 2024, closing a stake of 2,705 shares — an estimated $42.6K sold.

Ameritas Investment Partners first reported a position in ICVX in Q3 2021 and held it in 10 quarters. The position peaked at $42.6K in Q4 2023. 0 funds tracked by Wall St. Rank hold ICVX as of Q1 2024.

  • Ameritas Investment Partners reported no remaining Icosavax, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Ameritas Investment Partners sold 2,705 Icosavax, Inc. Common Stock shares in Q1 2024, an estimated $42.6K.
  • Ameritas Investment Partners first reported a position in Icosavax, Inc. Common Stock in Q3 2021 and held it in 10 quarters.
  • Ameritas Investment Partners's Icosavax, Inc. Common Stock position peaked at $42.6K in Q4 2023.
  • 0 funds tracked by Wall St. Rank held Icosavax, Inc. Common Stock as of Q1 2024.

Based on Ameritas Investment Partners's 13F filing for Q1 2024, filed 13 May 2024.